Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.42

Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.42). Revenue for the quarter came in at $20 million.

For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.

You May Also Be Interested In

• Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• BlackBerry shares gain premarket as Q2 results, guidance beat estimates